Add on effect of benfotiamine over pregabalin among patients with carpal tunnel syndrome in tertiary care specialty clinic – a randomized controlled trial
Journal Title: The Journal of Community Health Management - Year 2017, Vol 4, Issue 3
Abstract
Introduction: Carpal Tunnel syndrome is a common entrapment neuropathy involving the median nerve across the transverse carpal ligament. The diagnosis is clinical and confirmed by neurophysiological evaluation. Management varies from conservative as well as surgical. Since most of the patients prefer medical management we decided to compare the efficacy of benfotiamine, a neuro protective agent and pregabalin, a third generation anticonvulsant drug used for symptom relief. Aim: The study was conducted to compare the efficacy of pregabalin in combination with benfotiamine, and pregabalin as monotherapy in the management of carpal tunnel syndrome (CTS). Materials and Method: Fifty eight patients with CTS, who were diagnosed clinically and confirmed by nerve conduction study, were included through convenience sampling method. They were allocated to two groups: (i) treatment with pregabalin(n=30) and (ii) treatment with pregabalin in combination with benfotiamine (n=28) by simple randomization method. Symptom severity and functional status of these enrolled patients were compared before the intervention at recruitment and 12 weeks after the intervention using Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Result: The mean difference in symptom severity scale (SSS) and functional status scale(FSS) scores between two treatment groups were analyzed by intention to treat method. Statistically significant differences were observed after 12 weeks of treatment in the FSS and SSS in both the groups, compared to the baseline.Patients who received combination treatment had higher scores after 12 weeks in the FSS as well as the SSS compared to pregabalin group [12 weeks score in SSS: pregabalin: 0.33±0.29, pregabalin+benfotiamine group: 2.16±0.58, p=0.0001, mean reduction in FSS: pregabalin: 0.14± 0.25, pregabalin+benfotiamine group:1.81±0.24, p=0.0001]. Conclusion: Combining benfotiamine with pregabalin is found to be effective in the conservative management of Carpal Tunnel Syndrome due to the different modalities of action. The long term efficacy of these drugs needs to be studied.
Authors and Affiliations
S. Ramesh Kannan, Shanthi Kannan, Kalaiselvi Selvaraj, Manikandan .
Keywords
Related Articles
- EP ID EP294650
- DOI 10.18231/2394-2738.2017.0025
- Views 129
- Downloads 0
Depression and Anxiety in cases of COPD
Patients with chronic obstructive pulmonary disease (COPD) have many times under-recognized and untreated depression and anxiety symptoms which lead to harmful effects on physical functioning and social interaction. Depr...
A study on cardiovascular disease risk factors among faculty members of a tertiary care teaching institute of Kolkata
Introduction Medical faculty knows CVD risk factors and their prevention very well despite risk assessment and disease prevention efforts are lacking in this group due to their busy schedule and stress ObjectivesTo asses...
Health empowerment: Universal health care for the underprivileged
Tuberculosis: the current status in India
Pulmonary tuberculosis is endemic globally and is responsible for considerable morbidity and mortality. India is classified among the 22 high burden countries by WHO. According to WHO global TB report 2015 incidence of T...
Health profile and health insurance coverage among a defined rural population of Tumkur, Karnataka: A cross sectional study
To study the health profile of the population under study 3 To assess the health insurance coverage and utilization patterns in the study populationMaterials and Methods It is a Cross sectional study This study was unde...